Loading...
XJPX
5592
Market cap181mUSD
Dec 05, Last price  
2,569.00JPY
1D
-0.50%
1Q
-32.66%
IPO
35.57%
Name

Kusurinomadoguchi Inc

Chart & Performance

D1W1MN
XJPX:5592 chart
P/E
13.86
P/S
2.52
EPS
185.33
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
11.20b
+28.41%
6,489,257,0007,420,793,0008,721,460,00011,199,409,000
Net income
2.03b
+133.66%
515,609,000391,451,000870,921,0002,034,965,000
CFO
-5.33b
L
3,655,799,0003,096,744,0002,627,199,000-5,326,790,000
Dividend
Mar 30, 202630 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Health Tech Navi, an electronic medication history system; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.
IPO date
Oct 04, 2023
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFY
2025‑032024‑032023‑032022‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT